{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:17:46Z","timestamp":1794313066426,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acral melanoma is a dismal subtype of melanoma occurring in glabrous acral skin, and has a higher incidence in East Asians. We perform single-cell RNA sequencing for 63,394 cells obtained from 5 acral and 3 cutaneous melanoma samples to investigate tumor heterogeneity and immune environment. We define 5 orthogonal functional cell clusters that are involved in\n                    <jats:italic>TGF-beta<\/jats:italic>\n                    signaling, Type I interferon, Wnt signaling, Cell cycle, and Cholesterol efflux signaling. Signatures of enriched\n                    <jats:italic>TGF-beta<\/jats:italic>\n                    , Type I interferon, and cholesterol efflux signaling are significantly associated with good prognosis of melanoma. Compared with cutaneous melanoma, acral melanoma samples have significantly severe immunosuppressive state including depletion of cytotoxic CD8+ T cells, enrichment of Treg cells, and exhausted CD8+ T cells.\n                    <jats:italic>PD1<\/jats:italic>\n                    and\n                    <jats:italic>TIM-3<\/jats:italic>\n                    have higher expression in the exhaustive CD8+ T cells of acral melanoma. Key findings are verified in two independent validation sets. This study contributes to our better understanding of acral melanoma.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-34877-3","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:32:02Z","timestamp":1669393922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2522-1902","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tielong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-5698","authenticated-orcid":false,"given":"Haotian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-3853","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-7681","authenticated-orcid":false,"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-2152","authenticated-orcid":false,"given":"Xiangchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-3740","authenticated-orcid":false,"given":"Jilong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"34877_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/pcmr.12885","volume":"34","author":"P Basurto-Lozada","year":"2021","unstructured":"Basurto-Lozada, P. et al. Acral lentiginous melanoma: basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 34, 59\u201371 (2021).","journal-title":"Pigment Cell Melanoma Res."},{"key":"34877_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/jnci\/djz005","volume":"111","author":"I Yeh","year":"2019","unstructured":"Yeh, I. et al. Targeted genomic profiling of acral melanoma. J. Natl. Cancer Inst. 111, 1068\u20131077 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"34877_CR3","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","volume":"31","author":"FS Hodi","year":"2013","unstructured":"Hodi, F. S. et al. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J. Clin. Oncol. 31, 3182\u20133190 (2013).","journal-title":"J. Clin. Oncol."},{"key":"34877_CR4","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1158\/1078-0432.CCR-19-3922","volume":"26","author":"B Tang","year":"2020","unstructured":"Tang, B. et al. Safety, efficacy, and biomarker analysis of toripalimab in previously treated advanced melanoma: results of the POLARIS-01 multicenter phase II trial. Clin. Cancer Res. 26, 4250\u20134259 (2020).","journal-title":"Clin. Cancer Res."},{"key":"34877_CR5","doi-asserted-by":"crossref","unstructured":"Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti\u2013PD-1) in Melanoma. N. Engl. J. Med. 369, 134\u2013144 (2013).","DOI":"10.1056\/NEJMoa1305133"},{"key":"34877_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.annonc.2020.05.031","volume":"31","author":"Y Nakamura","year":"2020","unstructured":"Nakamura, Y. et al. Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients. Ann. Oncol. 31, 1198\u20131206 (2020).","journal-title":"Ann. Oncol."},{"key":"34877_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jmoldx.2012.10.002","volume":"15","author":"WO Greaves","year":"2013","unstructured":"Greaves, W. O. et al. Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J. Mol. Diagn. 15, 220\u2013226 (2013).","journal-title":"J. Mol. Diagn."},{"key":"34877_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pcmr.12279","volume":"27","author":"SJ Furney","year":"2014","unstructured":"Furney, S. J. et al. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment Cell Melanoma Res. 27, 835\u2013838 (2014).","journal-title":"Pigment Cell Melanoma Res."},{"key":"34877_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"34877_CR10","doi-asserted-by":"crossref","unstructured":"de Andrade, L. F. et al. Discovery of specialized NK cell populations infiltrating human melanoma metastases. JCI Insight 4, e133103 (2019).","DOI":"10.1172\/jci.insight.133103"},{"key":"34877_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013.e1020 (2018).","journal-title":"Cell"},{"key":"34877_CR12","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-21-3145","volume":"28","author":"J Li","year":"2022","unstructured":"Li, J. et al. Single-cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy. Clin. Cancer Res. 28, 2131\u20132146 (2022).","journal-title":"Clin. Cancer Res."},{"key":"34877_CR13","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.isci.2021.103200","volume":"24","author":"H Shen","year":"2021","unstructured":"Shen, H. et al. Miscell: an efficient self-supervised learning approach for dissecting single-cell transcriptome. iScience 24, 103200 (2021).","journal-title":"iScience"},{"key":"34877_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/pcmr.12459","volume":"29","author":"T Zhang","year":"2016","unstructured":"Zhang, T., Dutton-Regester, K., Brown, K. M. & Hayward, N. K. The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res. 29, 266\u2013283 (2016).","journal-title":"Pigment Cell Melanoma Res."},{"key":"34877_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"34877_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/annonc\/mdz019","volume":"30","author":"JE Stein","year":"2019","unstructured":"Stein, J. E. et al. Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response. Ann. Oncol. 30, 589\u2013596 (2019).","journal-title":"Ann. Oncol."},{"key":"34877_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz, N. et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171, 934\u2013949.e916 (2017).","journal-title":"Cell"},{"key":"34877_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/1346-8138.15201","volume":"47","author":"Y Lim","year":"2020","unstructured":"Lim, Y., Lee, J. & Lee, D. Y. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas? J. Dermatol. 47, 251\u2013256 (2020).","journal-title":"J. Dermatol."},{"key":"34877_CR19","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue, Y. & Nishikawa, H. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 110, 2080\u20132089 (2019).","journal-title":"Cancer Sci."},{"key":"34877_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","volume":"236","author":"LM Francisco","year":"2010","unstructured":"Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236, 219\u2013242 (2010).","journal-title":"Immunol. Rev."},{"key":"34877_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201847659","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka, A. & Sakaguchi, S. Targeting Treg cells in cancer immunotherapy. Eur. J. Immunol. 49, 1140\u20131146 (2019).","journal-title":"Eur. J. Immunol."},{"key":"34877_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.003","volume":"457","author":"R Saleh","year":"2019","unstructured":"Saleh, R. & Elkord, E. Treg-mediated acquired resistance to immune checkpoint inhibitors. Cancer Lett. 457, 168\u2013179 (2019).","journal-title":"Cancer Lett."},{"key":"34877_CR23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","volume":"76","author":"OF Kuzu","year":"2016","unstructured":"Kuzu, O. F., Noory, M. A. & Robertson, G. P. The role of cholesterol in cancer. Cancer Res. 76, 2063\u20132070 (2016).","journal-title":"Cancer Res."},{"key":"34877_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2020.02.036","volume":"477","author":"T Li","year":"2020","unstructured":"Li, T. et al. IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Lett. 477, 19\u201330 (2020).","journal-title":"Cancer Lett."},{"key":"34877_CR25","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.cell.2022.06.007","volume":"185","author":"J Biermann","year":"2022","unstructured":"Biermann, J. et al. Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. Cell 185, 2591\u20132608.e2530 (2022).","journal-title":"Cell"},{"key":"34877_CR26","unstructured":"Chen, X., Fan, H., Girshick, R. & He, K. Improved Baselines with Momentum Contrastive Learning (2020)."},{"key":"34877_CR27","doi-asserted-by":"crossref","unstructured":"He, K., Fan, H., Wu, Y., Xie, S. & Girshick, R. Momentum Contrast for Unsupervised Visual Representation Learning (2019).","DOI":"10.1109\/CVPR42600.2020.00975"},{"key":"34877_CR28","doi-asserted-by":"crossref","unstructured":"Bottou, L. In Neural Networks: Tricks Of The Trade. p. 421\u2013436 (Springer, 2012).","DOI":"10.1007\/978-3-642-35289-8_25"},{"key":"34877_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"34877_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41592-018-0308-4","volume":"16","author":"GC Linderman","year":"2019","unstructured":"Linderman, G. C., Rachh, M., Hoskins, J. G., Steinerberger, S. & Kluger, Y. Fast interpolation-based t-SNE for improved visualization of single-cell RNA-seq data. Nat. Methods 16, 243\u2013245 (2019).","journal-title":"Nat. Methods"},{"key":"34877_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).","journal-title":"Sci. Rep."},{"key":"34877_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"34877_CR33","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).","journal-title":"Nucleic Acids Res."},{"key":"34877_CR34","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.0913939107","volume":"107","author":"C Wang","year":"2010","unstructured":"Wang, C. et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc. Natl. Acad. Sci. USA 107, 1518\u20131523 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"34877_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"34877_CR36","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/44565","volume":"401","author":"DD Lee","year":"1999","unstructured":"Lee, D. D. & Seung, H. S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788\u2013791 (1999).","journal-title":"Nature"},{"key":"34877_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"34877_CR38","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/labinvest.2017.37","volume":"97","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies. Lab Invest. 97, 873\u2013885 (2017).","journal-title":"Lab Invest."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34877-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34877-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34877-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:46:16Z","timestamp":1669394776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34877-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34877"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34877-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-690139\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"9 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7250"}}